{"name":"Ibis Reproductive Health","slug":"ibis-reproductive-health","ticker":"","exchange":"","domain":"","description":"Charlotte Ellertson was a sociologist and public health researcher activist who specialized in emergency contraception and medication abortion. She founded Ibis Reproductive Health, an organization that advocates for sexual and reproductive health education and access. The organization, and Ellertson's work in it, is recognized as instrumental in the FDA approval of the abortion inducing pill RU-486. In 2013, HuffPost named Ellertson one of 50 most influential people in women's health.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Misoprostol-only medication abortion regimen","genericName":"Misoprostol-only medication abortion regimen","slug":"misoprostol-only-medication-abortion-regimen","indication":"Medical abortion (pregnancy termination up to 12 weeks gestation)","status":"marketed"}]}],"pipeline":[{"name":"Misoprostol-only medication abortion regimen","genericName":"Misoprostol-only medication abortion regimen","slug":"misoprostol-only-medication-abortion-regimen","phase":"marketed","mechanism":"Misoprostol is a prostaglandin analog that causes uterine contractions and cervical dilation to induce abortion.","indications":["Medical abortion (pregnancy termination up to 12 weeks gestation)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPYUJtak1oR1l2VEY4V3hSb2NIRVRidTk1OHk4ZXFmMWFTcDR0czdDY0d6alpiWHR3YUhYWHg3c19TbV9PUlMxQlowVDJWSU52WFdQUWFLNkl4RGViYWk3QTktM00zLURleEcxNUktSmN4ZVNDdU5aVnJpYVBUSFo3ZU9lQzZCSzNHeUh4N2JvbUNqU1lpaTh1QkVxX1dYY0FnSzFXbHpDSjlLWXYxcmhCdkRTZklYNGM0ajVEOVQyajZYZE1nRU0tNkxpUHVhZw?oc=5","date":"2025-04-02","type":"pipeline","source":"Reuters","summary":"Researchers, ACLU sue over Trump's 'ideological purge' of NIH grants - Reuters","headline":"Researchers, ACLU sue over Trump's 'ideological purge' of NIH grants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9YQzc0Y19TU09McFRpaVVsOHd5MGlpbDZzNU1EN3Y4Ymd0QmF2U0czbmh1SjA4T0Z3UlJRbnNYNjc0UXQxaUd0aDBVNnJQSjBxODU5a2tVYlFKX2s4bURickhFU29QaGxlWXFybldTNTVleEs1MGMxdw?oc=5","date":"2024-12-03","type":"pipeline","source":"newyorker.com","summary":"Is Contraception Under Attack? - newyorker.com","headline":"Is Contraception Under Attack?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOTFgxcVRDM1VOaVNGVTFSWXowelVGOG5TbFF1T1Nrak9JaE5yODBVUFNFVkh5UzdUYnZNTDBlWjFyTU5TdWt5VlNmbWt3Rk9iSFZxRFNQMlhOMlJWSE5xSVhobjlqVmNVaExtLWNsR0k2YUhEU2Nib0UyLUtfNkpyVS1GY0dVeTBDZmF3OHRBVGF1RE1nUUV5LVVQb1BJVDlDcGNwWDVHMFZrenVmdHk4cGs2SkluS2dQSjZHaXZUTko?oc=5","date":"2023-05-13","type":"regulatory","source":"Kansas Reflector","summary":"Health experts urge FDA to approve over-the-counter birth control in unanimous vote - Kansas Reflector","headline":"Health experts urge FDA to approve over-the-counter birth control in unanimous vote","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQOXI1TG5iX2g3akpmbmd3UEdNUklXa1NLbzdkb0NCOWxaeEZtRjhRQWhzUkpKUFh1bjJwbXF1bU1ZSF9vQ3dJeTgwOEkwcThyclhCMUNZNDFleGNxcG5wc0NCVWpVVDI4QU14LU5WdzcwMXlEb2FsZ1Z2OEp5N3RaTXpvOTVtcDZXekVYVUZR?oc=5","date":"2023-02-17","type":"pipeline","source":"Contemporary OB/GYN","summary":"OTC contraception access and patients of color - Contemporary OB/GYN","headline":"OTC contraception access and patients of color - Contemporary OB/GYN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPMy1WUmlnNW1IWi1WbVZyUDZONm5XMDYxZnY1ZGhmY1VSZ3ZzN1AzbjlzcGJEMFBSNWJDbkVORTFhS2ltLUJHd3AtZmpkbksxRllVTGlRUEFlN2pGTmpQZWs4cDlzYmg0UXl3dGliemJyT3FUMVM3dDVhQkFqX0FaamhpVEdISmIwSHpNN0h3RDRta19DcWpfeQ?oc=5","date":"2023-02-10","type":"pipeline","source":"fortune.com","summary":"U.S. women still can’t get birth control pills over the counter. Inside one company's 9-year struggle to change that - fortune.com","headline":"U.S. women still can’t get birth control pills over the counter. Inside one company's 9-year struggle to change that","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNQW5CXzF5ZFQ4NU1fQ3lyNC1zZEM4VjFQU19DM3BLVW1RcVROZE1WSkZpalVlVjUzUlRkbjhIMFVuOXN5RUhTb2dzRlRBQTRObzNaYndISEQ4MWRCcnRmNHF0TENUZUlFdi16cE16MzVmZFlHNzBVM3ZWTks0WFoxdzhxTlRHX3pQNU1OXzJQWHJhZC1uSzI0Q29XYlc?oc=5","date":"2022-08-03","type":"pipeline","source":"Ms. Magazine","summary":"The Back-and-Forth Feminist Fight for Over-the-Counter Birth Control - Ms. Magazine","headline":"The Back-and-Forth Feminist Fight for Over-the-Counter Birth Control","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNcGZNX2xkM09tRm5oUWFKeTJoYU5zZy1LN0ZPNjdtVTBwRXVNdVFScXJqM29DNXBiNzU5Sm1mUkRUdVVhMGdqTE8wR2ttam1HcWt5YzRWTnp6WHhVUVMzaGIwNDBIRHB6OUFGZVUwWDVZeHBNMENELVZyYnppSk8xaW5OSnY1ZEluc1JPSUt1WlY4dklDZGxUaEREUXpsdw?oc=5","date":"2022-07-19","type":"pipeline","source":"The Progressive","summary":"The Activist Offering: We Need Over-the-Counter Birth Control - The Progressive","headline":"The Activist Offering: We Need Over-the-Counter Birth Control","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1md0ZhSkFHUjB5ZmlwSFk2aFJtZy1SWnpOSmZibUtOOUNvWmpMcHE2VUdJcUk0NF9yZ0U4dVFucnpQZlB3aUhiRWxDaHBWVnJJOVBDNUZvTWRySEo5aTNMcDNrTnh3S3p1REZmMnJYNjhhNlU?oc=5","date":"2022-07-11","type":"pipeline","source":"Time Magazine","summary":"First Company Applies to Make Birth Control Pill Available Without a Prescription in the U.S. - Time Magazine","headline":"First Company Applies to Make Birth Control Pill Available Without a Prescription in the U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQQUFFcEV0bjg0VlpZVkwwX1RoNk1oMmNMeWpweW56ejQ1QTdOdHp2djF3clpOVm9WRk1YMF9OR0hUckVQVlFmandHLUc3SlFKSjVYaTFxVkRJT1Q2d09KN2lQRXIyX1FqOVdfQmY1dXNIdmhZbHVTdFFXVHhqSVR0Q3g1UWlsU1VLZHg5Q25B?oc=5","date":"2022-07-11","type":"pipeline","source":"The New York Times","summary":"F.D.A. to Weigh Over-the-Counter Sale of Contraceptive Pills (Published 2022) - The New York Times","headline":"F.D.A. to Weigh Over-the-Counter Sale of Contraceptive Pills (Published 2022)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-07-11","type":"regulatory","source":"NBC4 Washington","summary":"Drugmaker Seeks FDA Approval of First Over-The-Counter Birth Control Pill - NBC4 Washington","headline":"Drugmaker Seeks FDA Approval of First Over-The-Counter Birth Control Pill - NBC4 Washington","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPaGFHY1IwMlExTWQzX1NqTDE5a1Y4S1czT3p1dEE0MHpVZ2lDQVZnbFhWY3pnWENTTHMwSm5rbGZoN1M2VmxKY2pOZTFyNmR3ZHlQVWNxUWVQTXREbC1vajNnQXdZMHUzak9jbmxHU2hoYmU1SXJRb0xPa3l4cTE3M0VXd3ppbXhF?oc=5","date":"2022-02-16","type":"pipeline","source":"The Washington Informer","summary":"Advocacy Continues for OTC Birth Control Pill - The Washington Informer","headline":"Advocacy Continues for OTC Birth Control Pill","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNYWtMRlRPME1HRkFMYVphektnSDFCcUF4M3RGaXBkTlU2aW9lT0lrSE9RX09uR0U4dFItOW94a3hjenFJb213SHRDVXg0a00zR3NXWlNYUHdfMjBMME8yNjE1ZzRRUWhndWpScmVzM3I4eGVnTHB6N29SSTViWU9OWllIY0Q4M0YtRVRrUzBkdEtjQjcz?oc=5","date":"2016-12-30","type":"pipeline","source":"vox.com","summary":"The first steps toward over-the-counter birth control in the US are finally underway - vox.com","headline":"The first steps toward over-the-counter birth control in the US are finally underway","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}